<p>Lung IgG (A) and IgA (B), and serum IgG (C) and IgA (D) antibody responses to A/California/04/2009 virus were determined before (week 6.5 post immunization) and after challenge (day 4 post challenge) with the homologous virus A/California/04/2009. Lung and serum samples before and after challenge were collected at the same time (n = 6) and analyzed under the same assay condition (week 6.5 post-vaccination). Lung IgA (B) before and after challenge: P<0.05. Serum IgG (C) and IgA (D) responses before and after challenge from the A/California/04/2009 virus challenge: P<0.001. Low and moderate naïve backgrounds were observed in the serum and lung samples respectively and these values have been subtracted from the immune samples.</p
<br>Serum IgA, IgG, and IgG subclass responses specific for (A) OMV, (B) Ptx, (C) Prn, (D) FHA, and ...
<p>A) HI titer on day of re-challenge and peak infectious virus titer in tracheal secretions after r...
<p>A) Timeline for immunization and challenge. B) Influenza H5N1 virus specific serum IgG antibody t...
<p>ELISAs were performed using 23F or 6B pneumococci as targets to measure specific IgG (A, C and E)...
<p>Lung, serum, and spleen samples were collected from individual mice in each group (n = 6) at day ...
<p>Levels of IgG antibodies were determined in samples collected from mice at day 5 p.i. with A/Phil...
1<p>Virus specific IgG1 and IgG2a antibody responses were determined and compared among groups befor...
<p>ELISAs were performed using pneumococcal antigens PspA (A), PspC (B), PdB (C) and PsaA (D) to det...
<p>Data are presented as a function of the immunization group (A) or of the mammary ASR category fol...
<p>ELISAs were performed using pneumococcal antigens PspA (A), PspC (B), PdB (C) and PsaA (D) to det...
<p>A–B: IgG serum antibodies specific to A/California/04/2009 (A) or A/PR8/34 (B) H1N1 influenza vir...
<p>PPS3-specific total IgG (A), IgG3 (B), and IgM (C) antibody titers were measured by ELISA in Prev...
<p>Serum IgA, IgG, and IgG subclass responses specific for (A) OMV, (B) Ptx, (C) Prn, (D) FHA, and (...
<p>Graphs present scatterplots of pneumococcal serotype-specific IgG antibody titers pre- and 1 mont...
<p>Maximal PPD-specific PBMC IFN-γ responses post-vaccination and maximal rAg85A-specific IFN-γ resp...
<br>Serum IgA, IgG, and IgG subclass responses specific for (A) OMV, (B) Ptx, (C) Prn, (D) FHA, and ...
<p>A) HI titer on day of re-challenge and peak infectious virus titer in tracheal secretions after r...
<p>A) Timeline for immunization and challenge. B) Influenza H5N1 virus specific serum IgG antibody t...
<p>ELISAs were performed using 23F or 6B pneumococci as targets to measure specific IgG (A, C and E)...
<p>Lung, serum, and spleen samples were collected from individual mice in each group (n = 6) at day ...
<p>Levels of IgG antibodies were determined in samples collected from mice at day 5 p.i. with A/Phil...
1<p>Virus specific IgG1 and IgG2a antibody responses were determined and compared among groups befor...
<p>ELISAs were performed using pneumococcal antigens PspA (A), PspC (B), PdB (C) and PsaA (D) to det...
<p>Data are presented as a function of the immunization group (A) or of the mammary ASR category fol...
<p>ELISAs were performed using pneumococcal antigens PspA (A), PspC (B), PdB (C) and PsaA (D) to det...
<p>A–B: IgG serum antibodies specific to A/California/04/2009 (A) or A/PR8/34 (B) H1N1 influenza vir...
<p>PPS3-specific total IgG (A), IgG3 (B), and IgM (C) antibody titers were measured by ELISA in Prev...
<p>Serum IgA, IgG, and IgG subclass responses specific for (A) OMV, (B) Ptx, (C) Prn, (D) FHA, and (...
<p>Graphs present scatterplots of pneumococcal serotype-specific IgG antibody titers pre- and 1 mont...
<p>Maximal PPD-specific PBMC IFN-γ responses post-vaccination and maximal rAg85A-specific IFN-γ resp...
<br>Serum IgA, IgG, and IgG subclass responses specific for (A) OMV, (B) Ptx, (C) Prn, (D) FHA, and ...
<p>A) HI titer on day of re-challenge and peak infectious virus titer in tracheal secretions after r...
<p>A) Timeline for immunization and challenge. B) Influenza H5N1 virus specific serum IgG antibody t...